Ajertil, A., Jirari Rim, M’Benga. L.-J.K. and El Quessar, A. (2025) Severe and Rare Cerebrovascular Involvement in Systemic Lupus Erythematosus: Case Report and Literature Review. Open Access Library ...
Despite their frequency, many people misunderstand what a fever means, when it’s dangerous and how best to manage it. Here’s ...
Medpage Today on MSN
Here's Just How Much Lupus Damages the Heart
CHICAGO -- People who died with systemic lupus erythematosus (SLE) were far more likely than car crash victims to have severe ...
The Lupus Foundation of America (LFA) celebrated exceptional lupus researchers at the 20th Anniversary Evelyn V. Hess ...
Although overall mortality rates for patients with lupus have declined since the turn of the century, racial, sex and ...
CHICAGO — Enpatoran, a first-in-class oral small molecule toll-like receptor 7/8 inhibitor, is superior to placebo in ...
Actress, singer and makeup mogul Selena Gomez has been candid about her experience of living with lupus. Since 2015, Gomez has documented on social media and in interviews the effect the condition has ...
FDA approval based on superiority of Gazyva over standard therapy alone, as shown in Phase II NOBILITY and Phase III REGENCY data –– Gazyva is the only anti-CD20 monoclonal antibody to demonstrate a ...
The Food and Drug Administration (FDA) has approved Gazyva ® (obinutuzumab) for the treatment of adult patients with active lupus nephritis who are receiving standard therapy.
TipRanks on MSN
GSK’s LUNELORD Study: New Insights into Lupus Nephritis
GlaxoSmithKline (($GSK)) announced an update on their ongoing clinical study. Study Overview: The LUNELORD study, officially titled A Descriptive, ...
AstraZeneca has announced that Saphnelo (anifrolumab) has been recommended for approval in the European Union (EU) as a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback